Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0002096947-25-000001
Filing Date
2025-11-24
Accepted
2025-11-24 10:14:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 4640
  Complete submission text file 0002096947-25-000001.txt   6215
Mailing Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080 (415) 655-4168
SPRUCE BIOSCIENCES, INC. (Subject) CIK: 0001683553 (see all company filings)

EIN.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-91764 | Film No.: 251510027
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 5 CENTRAL SAINT GILES PIAZZA FLAT 56 LONDON OTHER (NON US) United Kingdom WC2H 8AB
Business Address
Boone Peter David Mr (Filed by) CIK: 0002096947 (see all company filings)

Type: SCHEDULE 13G